ARDENT HEALTH INC (ARDT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:ARDT • US03980N1072

8.94 USD
+0.36 (+4.2%)
At close: Feb 6, 2026
9.05 USD
+0.11 (+1.23%)
After Hours: 2/6/2026, 8:18:08 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall ARDT gets a fundamental rating of 5 out of 10. We evaluated ARDT against 102 industry peers in the Health Care Providers & Services industry. ARDT has only an average score on both its financial health and profitability. ARDT is valued quite cheap, while showing a decent growth score. This is a good combination! This makes ARDT very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ARDT had positive earnings in the past year.
  • In the past year ARDT had a positive cash flow from operations.
ARDT Yearly Net Income VS EBIT VS OCF VS FCFARDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.98%, ARDT is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
  • The Return On Equity of ARDT (16.56%) is better than 84.31% of its industry peers.
  • The Return On Invested Capital of ARDT (7.53%) is better than 70.59% of its industry peers.
  • ARDT had an Average Return On Invested Capital over the past 3 years of 5.96%. This is below the industry average of 9.16%.
  • The 3 year average ROIC (5.96%) for ARDT is below the current ROIC(7.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.98%
ROE 16.56%
ROIC 7.53%
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ARDT Yearly ROA, ROE, ROICARDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • ARDT has a Profit Margin of 3.24%. This is in the better half of the industry: ARDT outperforms 69.61% of its industry peers.
  • In the last couple of years the Profit Margin of ARDT has grown nicely.
  • With a decent Operating Margin value of 5.98%, ARDT is doing good in the industry, outperforming 68.63% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ARDT has grown nicely.
  • With an excellent Gross Margin value of 57.94%, ARDT belongs to the best of the industry, outperforming 81.37% of the companies in the same industry.
  • ARDT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.98%
PM (TTM) 3.24%
GM 57.94%
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
ARDT Yearly Profit, Operating, Gross MarginsARDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ARDT is destroying value.
  • The number of shares outstanding for ARDT has been increased compared to 1 year ago.
  • ARDT has a better debt/assets ratio than last year.
ARDT Yearly Shares OutstandingARDT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M
ARDT Yearly Total Debt VS Total AssetsARDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • ARDT has an Altman-Z score of 2.02. This is not the best score and indicates that ARDT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ARDT has a Altman-Z score of 2.02. This is comparable to the rest of the industry: ARDT outperforms 51.96% of its industry peers.
  • ARDT has a debt to FCF ratio of 7.03. This is a slightly negative value and a sign of low solvency as ARDT would need 7.03 years to pay back of all of its debts.
  • The Debt to FCF ratio of ARDT (7.03) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.88 indicates that ARDT is somewhat dependend on debt financing.
  • ARDT has a Debt to Equity ratio (0.88) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 7.03
Altman-Z 2.02
ROIC/WACC0.89
WACC8.43%
ARDT Yearly LT Debt VS Equity VS FCFARDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.08 indicates that ARDT has no problem at all paying its short term obligations.
  • ARDT's Current ratio of 2.08 is fine compared to the rest of the industry. ARDT outperforms 79.41% of its industry peers.
  • ARDT has a Quick Ratio of 1.95. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.95, ARDT belongs to the best of the industry, outperforming 80.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.95
ARDT Yearly Current Assets VS Current LiabilitesARDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 314.38% over the past year.
  • Measured over the past years, ARDT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.75% on average per year.
  • ARDT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.29%.
  • The Revenue has been growing slightly by 7.00% on average over the past years.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%205.88%
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%8.75%

3.2 Future

  • Based on estimates for the next years, ARDT will show a small growth in Earnings Per Share. The EPS will grow by 6.74% on average per year.
  • ARDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.17% yearly.
EPS Next Y-19.82%
EPS Next 2Y6.46%
EPS Next 3Y6.74%
EPS Next 5YN/A
Revenue Next Year8.67%
Revenue Next 2Y6.69%
Revenue Next 3Y6.36%
Revenue Next 5Y7.17%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ARDT Yearly Revenue VS EstimatesARDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
ARDT Yearly EPS VS EstimatesARDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 4.18, the valuation of ARDT can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of ARDT indicates a rather cheap valuation: ARDT is cheaper than 98.04% of the companies listed in the same industry.
  • ARDT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.92.
  • ARDT is valuated cheaply with a Price/Forward Earnings ratio of 6.41.
  • 97.06% of the companies in the same industry are more expensive than ARDT, based on the Price/Forward Earnings ratio.
  • ARDT is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.18
Fwd PE 6.41
ARDT Price Earnings VS Forward Price EarningsARDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ARDT is valued cheaper than 97.06% of the companies in the same industry.
  • ARDT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ARDT is cheaper than 89.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.13
EV/EBITDA 3.25
ARDT Per share dataARDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The decent profitability rating of ARDT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.46%
EPS Next 3Y6.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ARDT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARDENT HEALTH INC

NYSE:ARDT (2/6/2026, 8:18:08 PM)

After market: 9.05 +0.11 (+1.23%)

8.94

+0.36 (+4.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12
Earnings (Next)02-24
Inst Owners74.95%
Inst Owner Change-0.87%
Ins Owners1.98%
Ins Owner Change-0.01%
Market Cap1.28B
Revenue(TTM)6.33B
Net Income(TTM)205.06M
Analysts77.89
Price Target14.01 (56.71%)
Short Float %2.63%
Short Ratio5.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.03%
Min EPS beat(2)24.85%
Max EPS beat(2)71.2%
EPS beat(4)4
Avg EPS beat(4)53.83%
Min EPS beat(4)24.85%
Max EPS beat(4)76.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.13%
Min Revenue beat(2)-0.08%
Max Revenue beat(2)4.33%
Revenue beat(4)2
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-2.01%
Max Revenue beat(4)6.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.72%
PT rev (3m)-29.27%
EPS NQ rev (1m)-1.91%
EPS NQ rev (3m)-51.62%
EPS NY rev (1m)0.11%
EPS NY rev (3m)-47.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.54%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 4.18
Fwd PE 6.41
P/S 0.2
P/FCF 8.13
P/OCF 3.49
P/B 1.03
P/tB 4.73
EV/EBITDA 3.25
EPS(TTM)2.14
EY23.94%
EPS(NY)1.39
Fwd EY15.59%
FCF(TTM)1.1
FCFY12.3%
OCF(TTM)2.56
OCFY28.64%
SpS44.18
BVpS8.65
TBVpS1.89
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.41
Profitability
Industry RankSector Rank
ROA 3.98%
ROE 16.56%
ROCE 8.99%
ROIC 7.53%
ROICexc 8.81%
ROICexgc 12.04%
OM 5.98%
PM (TTM) 3.24%
GM 57.94%
FCFM 2.49%
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 7.03
Debt/EBITDA 2.05
Cap/Depr 137.15%
Cap/Sales 3.31%
Interest Coverage 250
Cash Conversion 69.06%
Profit Quality 76.79%
Current Ratio 2.08
Quick Ratio 1.95
Altman-Z 2.02
F-Score8
WACC8.43%
ROIC/WACC0.89
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%205.88%
EPS Next Y-19.82%
EPS Next 2Y6.46%
EPS Next 3Y6.74%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%8.75%
Revenue Next Year8.67%
Revenue Next 2Y6.69%
Revenue Next 3Y6.36%
Revenue Next 5Y7.17%
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year53.07%
EBIT Next 3Y17.14%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A

ARDENT HEALTH INC / ARDT FAQ

Can you provide the ChartMill fundamental rating for ARDENT HEALTH INC?

ChartMill assigns a fundamental rating of 5 / 10 to ARDT.


Can you provide the valuation status for ARDENT HEALTH INC?

ChartMill assigns a valuation rating of 8 / 10 to ARDENT HEALTH INC (ARDT). This can be considered as Undervalued.


Can you provide the profitability details for ARDENT HEALTH INC?

ARDENT HEALTH INC (ARDT) has a profitability rating of 6 / 10.


Can you provide the financial health for ARDT stock?

The financial health rating of ARDENT HEALTH INC (ARDT) is 5 / 10.